Venue: ICC – B2 Floor – Beylerbeyi Hall
Date:  12 September 2024
Timings: 12.30-14:00
Title: Decoding Gingivitis: Examining the prevalence, patient barriers, and efficacy of contemporary treatment.
Description: A symposium with presentations to share the latest data on prevalence of gum diseases in different countries as well as patient demography, barriers in treatment and new scientific evidence behind efficacy of sodium bicarbonate to enhance the mechanical clean in patients with gingivitis.
Corporate Sponsorship: Haleon
Learning Objectives:

  1. Understand the prevalence of gum diseases across different patient cohorts and countries.
  2. Understand the positive ROI for eliminating gingivitis in reducing the burden of periodontitis.
  3. Real World Patient barriers in maintaining clinical gingival health and consider the benefits of supporting mechanical cleaning with an appropriate adjunct.
  4. Understand the outcomes of the pooled analysis of the clinical studies (plaque removal and gum health improvement benefits) for a 67% sodium bicarbonate toothpaste.
  5. Understand the impact of sodium bicarbonate on gum health improvements in a no prophy clinical study.

Speakers


Venue: ICC – B2 Floor – Çamlıca Hall
Date:  12 September 2024
Timings: 12.30-14:00
Title:
Description:
Corporate Sponsorship: Wrigley Oral Healthcare
Learning Objectives:
Agenda of Symposium:
Speakers:

Venue: ICC – B2 Floor – Beylerbeyi Hall
Date:  13 September 2024
Timings: 12.30-14:00
Title:
Description:
Corporate Sponsorship: Colgate
Learning Objectives:
Agenda of Symposium:
Speakers:  

Venue: ICC – B2 Floor – Çamlıca Hall
Date:  13 September 2024
Timings: 12.30-14.00
Title: What Does The Data Say About Oral Antiseptics?  An EFP Guideline-Based Approach
Corporate Sponsorship: Listerine
Chair: Prof. Bahar Eren Kuru

Speakers


Business Objectives

  • Communicate the evidence-base data supporting the essentiality of adjunctive antiseptic rinses (focus on 4EO -Listerine) and the practical implication of this for grassroot DHCPs and their patients.
  • Create DHCP content library that can be leveraged post the congress by markets across all HCP core channels
  • Expand and nurture KOL speaker network to build trust and credibility with DHCPs.

Learning Objectives:

  • To practically define optimal conditions for the use of oral antiseptics by DHCPs and their patients, based on the recommendations of the S3-level EFP Clinical Practice Guideline
  • Explore the economic impact of gum related issues and importance of efficacious at home self-oral care.
  • Understand key indications, patient groups and clinical benefits of the adjunctive use of antiseptics in the periodontal care.
  • Understand how antiseptic rinses with 4 Essential Oils are effective adjuncts to mechanical oral hygiene methods. 

Venue: ICC – B2 Floor – Beylerbeyi Hall
Date:  14 September 2024
Timings: 12.30-14:00
Title: Dentine Hypersensitivity: An Enigma no more!
Description:  A symposium on the aetiology, prevalence and impact of dentine hypersensitivity on daily lives, including different management options for various case studies, with a focus on the most recent advances in the treatment of dentine hypersensitivity.
Corporate Sponsorship: Haleon and Sensodyne
Learning Objectives:

  1. Understand the causes and mechanism of dentine hypersensitivity
  2. Appreciate the prevalence of dentine hypersensitivity
  3. Comprehend the impact of dentine hypersensitivity on quality of life
  4. Understand the different management options.

Speakers

Venue: ICEC – Rumeli Level– Rumeli Hall
Date:  14 September 2024
Timings: 12.30-14:00
Title: The Economic Rationale for Investing in Oral Health
Description:  Oral health is critical for overall health and well-being, with direct links to other major health conditions including diabetes, heart disease and poor mental health. Poor oral health also has a negative impact on the global economy, and with oral diseases affecting an estimated 3.5 billion people each year, their economic burden totals $710 billion annually around the world. Yet oral health has long been left out of traditional healthcare systems and coverage, leading to consistent increases in both the prevalence of oral disease and the inequitable burden of disease among marginalized groups.

This panel discusses the economic rationale for investing in oral health, showcasing a recent paper from the World Economic Forum that makes a compelling case that oral health is linked with broader health care costs, employment and education outcomes, and overall health and wellbeing. The panel will discuss concrete action pathways for public, private and civil society leaders, for addressing the global epidemic of oral disease and leveraging the economic return on investment.

Moderator: Dympna Kavanaugh, Chief Dental Officer (Ireland)
Panelists:
Ty Greene, World Economic Forum
Marko Vujicic, American Dental Association
Maria Ryan, Colgate Palmolive
Benoit Varenne, World Health Organization